Colgate-Palmolive Company $CL Shares Bought by TD Waterhouse Canada Inc.

TD Waterhouse Canada Inc. lifted its stake in shares of Colgate-Palmolive Company (NYSE:CL) by 248.5% during the third quarter, Holdings Channel.com reports. The fund owned 87,410 shares of the company’s stock after purchasing an additional 62,327 shares during the period. TD Waterhouse Canada Inc.’s holdings in Colgate-Palmolive were worth $6,909,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently added to or reduced their stakes in CL. Grimes & Company Inc. increased its position in shares of Colgate-Palmolive by 1.0% during the 2nd quarter. Grimes & Company Inc. now owns 12,495 shares of the company’s stock valued at $1,136,000 after purchasing an additional 118 shares during the period. RFG Advisory LLC grew its holdings in Colgate-Palmolive by 1.4% during the second quarter. RFG Advisory LLC now owns 9,227 shares of the company’s stock worth $839,000 after acquiring an additional 123 shares during the period. Tiemann Investment Advisors LLC raised its position in Colgate-Palmolive by 2.1% in the second quarter. Tiemann Investment Advisors LLC now owns 6,083 shares of the company’s stock worth $553,000 after acquiring an additional 125 shares in the last quarter. Westside Investment Management Inc. lifted its holdings in Colgate-Palmolive by 85.5% in the 2nd quarter. Westside Investment Management Inc. now owns 282 shares of the company’s stock valued at $26,000 after acquiring an additional 130 shares during the last quarter. Finally, S.A. Mason LLC boosted its position in shares of Colgate-Palmolive by 3.9% during the 3rd quarter. S.A. Mason LLC now owns 3,499 shares of the company’s stock valued at $280,000 after purchasing an additional 130 shares in the last quarter. 80.41% of the stock is currently owned by institutional investors and hedge funds.

Colgate-Palmolive Stock Up 5.9%

Shares of Colgate-Palmolive stock opened at $90.28 on Friday. Colgate-Palmolive Company has a 1 year low of $74.54 and a 1 year high of $100.18. The company has a market cap of $72.77 billion, a P/E ratio of 25.29, a P/E/G ratio of 5.74 and a beta of 0.30. The company has a current ratio of 0.93, a quick ratio of 0.60 and a debt-to-equity ratio of 5.90. The stock has a 50-day moving average price of $80.77 and a 200 day moving average price of $81.43.

Colgate-Palmolive (NYSE:CL) last issued its earnings results on Friday, January 30th. The company reported $0.95 earnings per share for the quarter, beating analysts’ consensus estimates of $0.91 by $0.04. The company had revenue of $5.23 billion for the quarter, compared to the consensus estimate of $5.13 billion. Colgate-Palmolive had a return on equity of 333.39% and a net margin of 14.47%.The firm’s quarterly revenue was up 5.8% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.91 EPS. As a group, analysts expect that Colgate-Palmolive Company will post 3.75 EPS for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, February 13th. Shareholders of record on Wednesday, January 21st will be given a $0.52 dividend. The ex-dividend date is Wednesday, January 21st. This represents a $2.08 dividend on an annualized basis and a yield of 2.3%. Colgate-Palmolive’s dividend payout ratio is presently 58.26%.

Analysts Set New Price Targets

Several research firms recently commented on CL. Royal Bank Of Canada raised shares of Colgate-Palmolive from a “sector perform” rating to an “outperform” rating and set a $88.00 target price for the company in a research note on Tuesday, December 9th. Piper Sandler reiterated an “overweight” rating and set a $96.00 price objective on shares of Colgate-Palmolive in a research report on Friday. Morgan Stanley decreased their target price on Colgate-Palmolive from $96.00 to $87.00 and set an “overweight” rating on the stock in a report on Monday, November 3rd. TD Cowen cut their target price on Colgate-Palmolive from $90.00 to $86.00 and set a “buy” rating on the stock in a research report on Thursday, January 8th. Finally, Deutsche Bank Aktiengesellschaft set a $86.00 price target on Colgate-Palmolive in a research report on Friday, October 10th. Eleven investment analysts have rated the stock with a Buy rating and five have given a Hold rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $90.13.

More Colgate-Palmolive News

Here are the key news stories impacting Colgate-Palmolive this week:

• Positive Sentiment: Q4 results beat Street estimates — EPS of $0.95 vs. $0.91 expected and revenue above consensus; management cited strong pricing and brand leadership as drivers of performance. Colgate Q4 Earnings Top Estimates, Strong Pricing Drives Results
• Positive Sentiment: Management issued FY‑2026 revenue guidance that’s above consensus (guidance range provided), signaling confidence in sustained demand for essentials across key regions — a primary catalyst for the stock rally. Colgate-Palmolive forecasts upbeat annual sales as essentials spending holds firm
• Positive Sentiment: Core categories showed resilience — oral care and pet nutrition strength plus a Latin America rebound helped sales growth; Market commentary highlights this operating improvement as a near-term positive for margins and top-line momentum. Colgate-Palmolive’s Core Strength Lifts Q4 Results
• Positive Sentiment: Strong cash generation and shareholder returns: record operating cash flow and ~$2.9B returned to shareholders in the year — supports buyback/dividend expectations and investor confidence. Colgate-Palmolive Company Announces 4th Quarter and Full Year 2025 Results
• Neutral Sentiment: Analysts and models are being updated after the print — some price‑target revisions were posted ahead/after the call; watch analyst notes for guidance sensitivity and margin assumptions. Colgate-Palmolive Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
• Negative Sentiment: Company recorded a large goodwill/intangible impairment tied to its skin‑health business that drove a GAAP loss for the quarter — this one‑time charge reduced headline EPS and highlights ongoing challenges in that segment. Colgate-Palmolive Swings to a Loss on Charges
• Negative Sentiment: Softer trends in China and margin pressure in parts of the portfolio were noted on the call — a reminder the recovery is uneven and could limit upside if those regions don’t stabilize. Colgate-Palmolive’s Core Strength Lifts Q4 Results

About Colgate-Palmolive

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.